News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by biote Corp.
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
June 20, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Definitive Settlement with Founder
April 29, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
April 23, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call
February 27, 2024
From
Biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
February 20, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces $20 Million Share Repurchase Authorization
January 25, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
January 17, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote to Purchase Asteria Health
January 17, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Names Robert Peterson as Chief Financial Officer
January 11, 2024
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
October 24, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call
July 27, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division
June 22, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote to Participate at Upcoming Investor Conferences
May 31, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
May 30, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
April 26, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote to Present at 35th Annual Roth Conference
March 02, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
February 09, 2023
From
Biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters’ Over-Allotment Option
January 09, 2023
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote to Present at Jefferies London Healthcare Conference
November 10, 2022
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Appoints Debby Morris to Board of Directors
November 07, 2022
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call
October 31, 2022
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Strategic Partnership with IMAC Holdings, Inc.
September 07, 2022
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Approval to Relist on The Nasdaq Stock Market
August 25, 2022
From
Biote Corp.
Via
Business Wire
Tickers
BTMD
Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022
July 20, 2022
From
biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer
June 16, 2022
From
Biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Announces Participation in the Jefferies Healthcare Conference 2022
June 06, 2022
From
Biote Corp.
Via
Business Wire
Tickers
BTMD
Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry
May 26, 2022
From
Biote Corp.
Via
Business Wire
Tickers
HYAC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close